Vigil Neuroscience, Inc.
NASDAQ:VIGL
3.57 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.399 | 1.01 | 0.345 | 0 |
| Gross Profit
| -0.399 | -1.01 | -0.345 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 60.934 | 47.444 | 32.33 | 4.514 |
| General & Administrative Expenses
| 27.932 | 21.44 | 10.079 | 3.554 |
| Selling & Marketing Expenses
| -0.399 | 0 | 0 | 1.773 |
| SG&A
| 27.932 | 21.44 | 10.079 | 1.777 |
| Other Expenses
| 0 | -0.044 | -0.877 | 0 |
| Operating Expenses
| 88.866 | 68.884 | 42.409 | 6.291 |
| Operating Income
| -88.866 | -68.884 | -42.409 | -6.291 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 6.228 | 0.579 | -0.874 | -22.255 |
| Income Before Tax
| -82.638 | -68.305 | -43.283 | -28.546 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -0.579 | -0.031 | -0.013 |
| Net Income
| -82.638 | -67.726 | -43.252 | -28.546 |
| Net Income Ratio
| 0 | 0 | 0 | 0 |
| EPS
| -2.13 | -2.14 | -28.24 | -1.01 |
| EPS Diluted
| -2.13 | -2.14 | -28.24 | -1.01 |
| EBITDA
| -88.467 | -68.884 | -42.409 | -6.291 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 |